Search Within

Han Liu

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (5)
  2. Department of Pathology and Laboratory Medicine (5)
  3. Epidemiology and Biostatistics (5)
  4. GSK Faculty (5)
  5. Genitourinary Oncology Service (5)
  6. Human Oncology and Pathogenesis Program (5)

More Groups

People
  1. Abraham Hakimi (5)
  2. Emily Cheng (5)
  3. James Hsieh (5)
  4. Martin Voss (5)
  5. Paul Russo (5)
  6. Robert Motzer (5)

More People

Years
  1. 2014 (1)
  2. 2013 (3)
  3. 2012 (1)
Publications
  1. Clinical Cancer Research (2)
  2. BJU International (1)
  3. Cancer Research (1)
  4. European Urology (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Elsevier Science, Inc. (1)
  3. Wiley Blackwell (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA research network
    Journal Article

    Hakimi, A. A.; Ostrovnaya, I.; Reva, B.; Schultz, N.; Chen, Y. B.; Gonen, M.; Liu, H.; Takeda, S.; Voss, M. H.; Tickoo, S. K.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; Reuter, V. E.; more...
    European Urology (2013)

    Fulltext@MSK | Save
  • Tumor suppressor screens of 3p chromatin modulators link BAP1 mutations to poor clinical outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Ostrovnaya, I.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; more...
    BJU International (2012)

    Fulltext@MSK | Save